Reprogrammed lipid metabolism in advanced resistant cancers: an upcoming therapeutic opportunity
Cioce, M.; Arbitrio, M.; Polera, N.; Altomare, E.; Rizzuto, A.; De Marco, C.; Fazio, V. M.; Viglietto, G.; Lucibello, M.
CANCER DRUG RESISTANCE
IF WOS: NA SJR: 1.495 Best Quartile: Q1
Posizione: 9/9

Harnessing the value of TCTP in breast cancer treatment resistance: an opportunity for personalized therapy
Santamaria, Gianluca; Cioce, Mario; Rizzuto, Antonia; Michele Fazio, Vito; Viglietto, Giuseppe; Lucibello, Maria
CANCER DRUG RESISTANCE
IF WOS: NA SJR: 1.035 Best Quartile: Q1
Posizione: 6/6